Published in Oral Oncol on December 01, 2011
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol (2008) 2.85
Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol (2007) 2.18
Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol (2003) 1.55
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol (2009) 1.37
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist (2012) 1.34
Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer (2013) 1.25
Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene (2004) 1.17
Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol (2005) 1.16
Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma. Clin Cancer Res (2007) 1.07
Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope (2006) 1.00
Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer. Oral Oncol (2009) 0.97
Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol (2007) 0.96
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer. Int J Oncol (2013) 0.95
Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head Neck (2011) 0.92
Initial multi-institutional experience with transoral robotic surgery. Otolaryngol Head Neck Surg (2012) 0.92
Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol (2005) 0.91
Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach. Oral Oncol (2004) 0.91
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course. Breast Cancer Res Treat (2011) 0.87
Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck (2008) 0.86
Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol (2009) 0.86
Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys (2005) 0.86
Nodal recurrence of sinonasal cancer: does the risk of cervical relapse justify a prophylactic neck treatment? Oral Oncol (2012) 0.85
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck (2006) 0.85
O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma. Invest New Drugs (2008) 0.84
Proposal for size justification of expanded cohort at phase-2-recommended dose. Invest New Drugs (2010) 0.82
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial. Target Oncol (2013) 0.82
Psychosocial factors involved in delayed consultation by patients with head and neck cancer. Head Neck (2005) 0.82
Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer (2004) 0.81
A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa. Oral Oncol (2006) 0.81
Head and neck cancer surgery in the elderly--does age influence the postoperative course? Oral Oncol (2009) 0.80
Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage? J Vasc Access (2014) 0.80
MRI definition of target volumes using fuzzy logic method for three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2003) 0.80
Advanced Abrikossoff tumour: a metastatic or a multifocal malignancy? Acta Oncol (2011) 0.80
Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. BJOG (2004) 0.79
Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study. Support Care Cancer (2004) 0.79
[A prospective evaluation of antibiotic prophylaxis efficacy for breast cancer surgery following previous chemotherapy]. Bull Cancer (2004) 0.79
Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol (2007) 0.78
Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study. Head Neck (2004) 0.78
Induction chemotherapy in head and neck cancer: a new paradigm. Anticancer Drugs (2011) 0.78
Treatment of laryngeal cancer: the permanent challenge. Expert Rev Anticancer Ther (2004) 0.77
Vacuum-assisted closure therapy in the management of patients undergoing vulvectomy. Eur J Obstet Gynecol Reprod Biol (2012) 0.76
Sinonasal cancer: Analysis of oncological failures in 156 consecutive cases. Head Neck (2013) 0.76
Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only? Ann Surg Oncol (2014) 0.76
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors. Med Oncol (2012) 0.75
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys (2006) 0.75
[Screening pelvic tumours for hereditary risk of ovarian neoplasms, a cancer center experience]. Bull Cancer (2011) 0.75
Transoral minimally invasive robotic surgery for carcinoma of the pharynx and the larynx: a new approach. Anticancer Drugs (2011) 0.75
Survival prognostic factors for lateral bucco-pharyngeal junction squamous cell carcinoma. Eur Arch Otorhinolaryngol (2007) 0.75
Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer. Bull Cancer (2012) 0.75
Anatomic variations of cervical internal carotid artery course: surgical implications. J Otolaryngol (2003) 0.75
[Methodological approaches of clinical studies with targeted therapies]. Bull Cancer (2008) 0.75
[Induction chemotherapy and larynx preservation: is such practice useful?]. Bull Cancer (2002) 0.75
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. Oncology (2008) 0.75
Single-port access laparoscopic surgery in gynecologic oncology: outcomes and feasibility. Int J Gynecol Cancer (2014) 0.75